Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Midas Pharma
Midas Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ranivisio
Ranibizumab
2022-08-25
Diabetes complications
,
Macular edema
,
Retinal vein occlusion
,
Diabetic retinopathy
,
Wet macular degeneration
,
Choroidal neovascularization
,
Degenerative myopia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Angiotensin ii
healthy volunteers/patients
,
nephrotic syndrome
,
nephrosis
,
hypertrophic cardiomyopathy
,
cardiomyopathies
,
pain
,
peripheral nervous system diseases
,
diabetic neuropathies
,
neuralgia
,
postherpetic neuralgia
,
ischemia
,
acute coronary syndrome
,
myocardial ischemia
,
sickle cell anemia
,
breast neoplasms
,
male breast neoplasms
,
covid-19
,
chronic renal insufficiency
,
hypercholesterolemia
,
myocardial infarction
,
infarction
,
inferior wall myocardial infarction
,
hypertension
,
heart failure
,
essential hypertension
,
systolic murmurs
,
diabetes mellitus
,
kidney diseases
,
metabolic syndrome
,
hypertrophy
,
syndrome
,
type 2 diabetes mellitus
,
left ventricular hypertrophy
,
diabetic nephropathies
,
systolic heart failure
,
isolated systolic hypertension
,
hypersensitivity
,
proteinuria
,
albuminuria
,
diastolic heart failure
,
dyslipidemias
,
insulin resistance
,
overweight
,
chagas disease
,
left ventricular dysfunction
,
mitral valve insufficiency
,
ventricular dysfunction
,
glomerulonephritis
,
iga glomerulonephritis
,
membranous glomerulonephritis
,
focal segmental glomerulosclerosis
,
nephrosclerosis
,
coronary artery disease
,
atrial fibrillation
,
glucose intolerance
,
prehypertension
,
stroke
,
angina pectoris
,
microvascular angina
Ccb
dental anxiety
,
restless legs syndrome
,
psychomotor agitation
,
syndrome
,
postoperative pain
,
spinal cord injuries
,
hiv infections
,
osteoarthritis
,
depression
,
spinal cord diseases
,
sleep wake disorders
,
inguinal hernia
,
hernia
,
wounds and injuries
,
acquired immunodeficiency syndrome
,
radiculopathy
,
anxiety
,
healthy volunteers/patients
,
neuralgia
,
seizures
,
myofascial pain syndromes
,
fibromyalgia
,
hypertension
,
peripheral nervous system diseases
,
epilepsy
,
diabetic neuropathies
,
partial epilepsies
,
pain
,
postherpetic neuralgia
,
anxiety disorders
,
dyslipidemias
,
hypercholesterolemia
,
angina pectoris
,
hyperlipidemias
,
low back pain
,
back pain
,
complex partial epilepsy
,
neoplasms
,
bone neoplasms
,
intractable pain
,
hyperlipoproteinemias
,
myocardial ischemia
,
stable angina
,
pharmacovigilance
,
hyperlipoproteinemia type ii
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use